Alteration in Plasma Metabolome in High-Fat Diet-Fed Monocyte Chemotactic Protein-1 Knockout Mice Bearing Pulmonary Metastases of Lewis Lung Carcinoma. (August 2022)

• Record Type: Journal Article
• Authors: Yan, Lin; Rust, Bret M; Sundaram, Sneha; Picklo, Matthew J; Bukowski, Michael R
• Is Part Of: Nutrition and metabolic insights. Volume 15(2022)
• Publication Date: 2022-08
• Subjects: Metabolome -- plasma -- MCP-1 -- metastasis -- Lewis lung carcinoma -- diet -- mice; Nutrition -- Periodicals; Metabolism -- Periodicals; Nutritional Physiological Phenomena -- Periodicals; Metabolism -- Periodicals; Metabolism; Nutrition; Electronic journals; Periodicals; 572.405
• DOI: 10.1177/11786388221111126
• Languages: English
• ISSNs: 1178-6388

Abstract

Both clinical and laboratory studies have shown that monocyte chemotactic protein-1 (MCP-1) is involved in cancer spread. To understand the role of MCP-1 in metabolism in the presence of metastasis, we conducted an untargeted metabolomic analysis of primary metabolism on plasma collected from a study showing that MCP-1 deficiency reduces spontaneous metastasis of Lewis lung carcinoma (LLC) to the lungs in mice fed a high-fat diet (HFD). In a 2 × 2 design, wild-type (WT) or Mcp-1 knockout ( Mcp-1 -/- ) mice maintained on the AIN93G standard diet or HFD were subcutaneously injected with LLC cells to induce lung metastasis. We identified 87 metabolites for metabolomic analysis from this study. Amino acid metabolism was altered considerably in the presence of LLC metastases with the aminoacyl-tRNA biosynthesis pathways as the leading pathway altered. The HFD modified lipid and energy metabolism, evidenced by lower contents of arachidonic acid, cholesterol, and long-chain saturated fatty acids and higher contents of glucose and pyruvic acid in mice fed the HFD. These findings were supported by network analysis showing alterations in fatty acid synthesis and glycolysis/gluconeogenesis pathways between the 2 diets. Furthermore, elevations of the citrate cycle intermediates (citric acid, fumaric acid, isocitric acid, and succinic acid) and glyceric acid in Mcp-1 -/- mice, regardless of diet, suggest the involvement of MCP-1 in mitochondrial energy metabolism during LLC metastasis. The present study demonstrates that MCP-1 deficiency and the HFD altered plasma metabolome in mice bearing LLC metastases. These findings can be useful in understanding the impact of obesity on prevention and treatment of cancer metastasis.